COVID-19 vaccines in elderly subjects: Considerations on efficacy and safety
<p>The SARS-CoV-2 pandemic dramatically involved elderly subjects, causing a very high number of deaths in this specific population, with a risk of mortality reaching 50% in subjects older than 80 years [1-3]. As a consequence, as the world prepares for a mass campaign to vaccinate as many peo...
Sábháilte in:
Príomhchruthaitheoir: | |
---|---|
Formáid: | LEABHAR |
Foilsithe / Cruthaithe: |
Archives of Clinical Gastroenterology - Peertechz Publications,
2021-05-19.
|
Ábhair: | |
Rochtain ar líne: | Connect to this object online. |
Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
Ar líne
Connect to this object online.3rd Floor Main Library
Gairmuimhir: |
A1234.567 |
---|---|
Cóip 1 | Ar fáil |